Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein kinase C delta (PKCδ) is a member of the novel PKC subfamily of serine/threonine kinases that plays a pivotal role in cellular signaling, particularly in response to oxidative stress and ischemia (UniProt P18056). A critical pathological mechanism involves the translocation of PKCδ from the cytosol to the mitochondria, where it interacts with the kinase regulatory domain of the Pyruvate Dehydrogenase (PDH) complex (Churchill et al., 2008, Nature 452:753-757). This interaction leads to the phosphorylation and inhibition of PDH, which suppresses oxidative phosphorylation (OXPHOS), reduces ATP production, and promotes the generation of reactive oxygen species (ROS) (Murriel et al., 2004, JBC 279:47}
Selective inhibition of PKCδ translocation to the mitochondria or inhibition of its kinase activity to prevent the phosphorylation and inactivation of the pyruvate dehydrogenase (PDH) complex, thereby maintaining oxidative phosphorylation (OXPHOS) and reducing mitochondrial-driven apoptosis.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein kinase C delta (PKCδ) (PKCδ).